| Source of record | UK Trials |
| ISRCTN | ISRCTN43192662 |
| Date ISRCTN assigned | 26/02/2008 |
| Local reference number(s) | V#1, 10/01/06 |
| Public title | An evaluation of a brief assessment led intervention with young non-injecting drug users |
| Scientific title |
|
| Acronym | N/A |
| Disease/condition/study domain | Substance misuse |
| Study hypothesis | That participants receiving a brief assessment led intervention would at 3 months follow-up have a lower mean frequency of cannabis use, cocaine use, crack cocaine use and MDMA (3,4 methylenedioxymethamphetamine; Ecstasy) use combined than delayed assessment control participants |
| Design/methodology | Randomised controlled trial |
| Research ethics review | King's College London. Date of approval: 17/10/2005 (ref: 05/Q0706/219) |
| Countries of trial | United Kingdom |
| Participants - inclusion criteria | 1. Sixteen to 28 years old 2. Using either cannabis, cocaine powder, crack cocaine, or MDMA on four days in previous month 3. Able speak and comprehend English 4. Written consent |
| Participants - exclusion criteria | 1. In contact with a drug/alcohol treatment agency in previous 12 months 2. Used opiates more than 30 days in the previous 90 days or in the previous 48 hours before interview 3. Injected more than once in the last 12 months and no more than ten times lifetime 4. Receiving specialist treatment for a mental health problem 5. Participated in a similar research study in the previous 12 months |
| Patient information material |
|
| Anticipated start date | 01/10/2005 |
| Anticipated end date | 29/01/2008 |
| Status of trial | Completed |
| Target number of participants | 255 |
| Interventions | Experimental: A brief assessment led intervention a. Drugs and Lifestyle Assessment b. Manual guided 30 minute feedback interview Control 1: Assessment only Control 2: Delayed assessment |
| Primary outcome measure(s) | Combined frequency of cocaine powder use, crack cocaine use, MDMA use and cannabis use, assessed at baseline and 90 days. |
| Secondary outcome measure(s) | The following were assessed at baseline and 90 days: 1. Typical intensity of cannabis use, cocaine use, crack cocaine use and MDMA use at 90 days 2. Drug dependency: Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) Personality Disorders (Structured Clinical Interview for DSM-IV Axis II Personality Disorders; SCID-II) 3. Alcohol frequency and intensity 4. Hazardous drinking: The Alcohol Use Disorders Identification Test (AUDIT) 5. General health: EQ-5D A multi-dimensional Quality of Health Instrument (EurQol) 6. Psychological health: General Health Questionnaire (GHQ 12) 7. Engagement with health and social services |
| Sources of funding | Department of Health of England & Wales, Drug Misuse Research Initiative (Phase 2) (UK) |
| Sponsor name | King's College London (UK) |
| Sponsor details | Institute of Psychiatry Kings College London 4 Windsor Walk London United Kingdom SE5 8AF |
| Sponsor email | gill.lambert@iop.kcl.ac.uk |
| Sponsor website | http://www.iop.kcl.ac.uk |
| Contact name | Dr John Marsden |
| Contact details | Institute of Psychiatry King's College London PO Box 048 4 Windsor Walk London United Kingdom SE5 8AF |
| Contact email | J.Marsden@iop.kcl.ac.uk |
| More information | For more up-to-date information please go to the ISRCTN link below. |
| Link to record in ISRCTN Register | ISRCTN43192662 |
| Date last extracted from ISRCTN register | 17/04/2008 |